An FDA committee will discuss Moderna boosters. Here's what to expect

An FDA committee will discuss Moderna boosters. Here's what to expect
·3 min read

This week marks another potential watershed moment for Moderna Inc.'s Covid-19 vaccine: A key advisory committee to the U.S. Food and Drug Administration is set to meet to discuss so-called "booster shots."

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting